Tanke Biosciences Corporation (TNBI)

Tanke Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Net Income	-0.1	-0.72	-0.21	-3.14	2.74
Depreciation & Amortization	-	-	0.64	0.4	0.14
Other Amortization	-	-	3.58	3.18	-
Stock-Based Compensation	0.07	0.66	-	2.49	-
Provision & Write-off of Bad Debts	-	-	0.1	0.09	-
Other Operating Activities	-0.03	0.05	-0.02	0.04	0.96
Change in Accounts Receivable	-	-	-0.17	-0.17	-0.24
Change in Inventory	-	-	-0.23	0.17	-0.33
Change in Accounts Payable	-	-	-0.14	0.15	0.56
Change in Unearned Revenue	-	-	-0.32	0.27	-0.08
Change in Income Taxes	-	-	0.63	0.48	0.4
Change in Other Net Operating Assets	0	0	-5.06	-0.29	0.23
Operating Cash Flow	-0.06	-0	-1.18	3.65	4.38
Operating Cash Flow Growth	-	-	-	-16.69%	152.07%
Capital Expenditures	-	-	-0.86	-0.7	-2.97
Cash Acquisitions	-	-	0.19	0.08	-
Sale (Purchase) of Intangibles	-	-	-0.48	-0.53	-
Other Investing Activities	-	-	-	-	0.15
Investing Cash Flow	-	-	-1.53	-3.67	-2.82
Short-Term Debt Issued	0.03	0.05	-	-	-
Long-Term Debt Issued	-	-	0.65	6.52	-
Total Debt Issued	0.03	0.05	0.65	6.52	-
Long-Term Debt Repaid	-	-	-	-	-0.89
Net Debt Issued (Repaid)	0.03	0.05	0.65	6.52	-0.89
Other Financing Activities	-	-	0.47	-0.71	-0.33
Financing Cash Flow	0.03	0.05	1.12	5.82	-1.22
Foreign Exchange Rate Adjustments	-	-	0.06	-0.32	0.06
Net Cash Flow	-0.03	0.04	-1.53	5.48	0.4
Free Cash Flow	-0.06	-0	-2.04	2.95	1.41
Free Cash Flow Growth	-	-	-	108.71%	-15.23%
Free Cash Flow Margin	-	-	-7.14%	12.39%	7.04%
Free Cash Flow Per Share	-0.01	-	-0.15	0.23	0.13
Cash Interest Paid	-	-	0.63	0.65	0.1
Cash Income Tax Paid	-	-	0.35	0.25	0.18
Levered Free Cash Flow	-0.07	-	-1.06	-1.04	1
Unlevered Free Cash Flow	-0.07	-	-1.99	-1.82	1.07
Change in Working Capital	0	0	-5.27	0.59	0.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.